0       0

2019 Scientific Sessions On-Demand


SSLIVE14 - Clinical Controversies in Pulmonary Hypertension


Nov 16, 2019 3:45pm ‐ Nov 16, 2019 5:00pm

Description

Oral Anticoagulant Therapy and DigoxinSteeve Provencher

PAH Specific Medications in Non-PAH PH - Marco Guazzi

Role of Genetic Screening in Incident PAH and Determinants of Survival, and Screening for PH in Asymptomatic Mutation CarriersMary Mullen

Significance of a Low DLCO in IPAH, PVOD, HFpEF and CTEPH -Harm Bogaard

Clinical Controversies in Pulmonary HypertensionPanel Discussion

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content